This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LaRue, L. J. Articles by Kleiner, J. Search for Related Content PubMed PubMed Citation Articles by LaRue, L. J. Articles by Kleiner, J. Pubmed/NCBI databases Medline Plus Health Information Clinical Trials

Stroke, Vol 19, 950-954, Copyright © 1988 by American Heart Association

ARTICLES

Acute stroke therapy trials: problems in patient accrual

LJ LaRue, M Alter, ND Traven, AB Sterman, E Sobel and J Kleiner
Neuroepidemiology Section, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Temple University Hospital participated in a multicenter acute stroke trial but enrolled only one patient out of 192 screened over 2 years; other centers had similar difficulty in patient recruitment. We analyzed our screening data to determine which enrollment criteria created difficulties in recruitment and whether the problem was attributable to any single criterion or to combinations of criteria. Six individual criteria were frequent causes for exclusion; however, greater than 80% of the patients were excluded for multiple reasons. Consequently, modifying or eliminating any single criterion did not appreciably increase patient accrual. Only 17 of 210 possible pairs of criteria occurred with statistically significant frequency (p less than 0.05), and these were most likely random associations. Therefore, only by minimizing the number and stringency of enrollment criteria will patient accrual be at a level that allows the study to be completed in a timely manner with a fiscally reasonable number of centers.

This article has been cited by other articles:

				S. C. Howard, A. Algra, C. P. Warlow, and P. M. Rothwell Potential Consequences for Recruitment, Power, and External Validity of Requirements for Additional Risk Factors for Eligibility in Randomized Controlled Trials in Secondary Prevention of Stroke Stroke, January 1, 2006; 37(1): 209 - 215. [Abstract] [Full Text] [PDF]

				T. G. Lukovits, K. Thomas, and P. B. Gorelick Stroke prevention trials: How many enrollees can be expected by site? Neurology, March 1, 1999; 52(5): 1101 - 1101. [Full Text]

				P. J. Dorman and P. A.G. Sandercock Considerations in the Design of Clinical Trials of Neuroprotective Therapy in Acute Stroke Stroke, September 1, 1996; 27(9): 1507 - 1515. [Full Text]